Hindiston
Hindiston dunyoning saraton poytaxti deb e'lon qilindi - Apollon hisoboti
India declared cancer capital of the world India was designated as the "cancer capital of the world" in the 4th edition of Apollo Hospitals' Health of the Nation Report, which was published on World Health Day 2024. According ..
Xitoy, Hindiston
Qanday qilib diagnostik tasvir ko'p miyeloma janglarida hayotni saqlab qoladi?
Curious about how a medical technique is saving the lives of multiple myeloma patients? Read our blog to learn more about this life-saving technique! Let's turn the page on cancer together. Your story of hope starts here. Hell..
Hindiston
2023 yilda Hindistondagi eng yaxshi saraton kasalxonalari
Here's the list of the best cancer hospitals in India:. The list is very carefully prepared, keeping in mind the use of the latest technology to treat cancer, ongoing research projects in the hospital, ongoing clinical trials in ..
Beta talassemiya, BMT, Covid-19, Hindiston, Talassemi
Beta Talassemiya va uni COVID-19 bilan ko'rib chiqish
2021 yil iyul: Beta-talassemiya - gemoglobin tarkibiy qismi, ya'ni butun tanada kislorodni tashiydigan oqsil ishlab chiqarishda ishtirok etuvchi gen mutatsiyalari natijasida kelib chiqqan irsiy kasallik. Bu mutatsiyalar yoki taqiqlaydi..
Bariatrik jarrohlik, Dehli, Hindiston, AQSH
Bariatrik jarrohlik melanoma xavfini kamaytirishi mumkin
Tezda va davomli vazn yo'qotish va sog'liq uchun boshqa foydali narsalardan tashqari, bariatrik jarrohlik hozirgi kunda malign melanoma xavfining 61% kamayishi bilan bog'liq bo'lib, bu haddan tashqari s bilan eng xavfli o'lik teri saratoni hisoblanadi.
CAR - T Uyali terapiya, Xitoy, Hindiston, muomala, AQSH
Multipl miyeloma immunoterapiyasining yangi strategiyasi
So'nggi o'n yilliklarda monoklonal antikorlarga asoslangan saraton kasalligi qattiq o'smalar va qon saratonlarini davolashning eng muvaffaqiyatli strategiyasidan biri sifatida belgilandi. Nomidan ko'rinib turibdiki, monoklonal antikorlar (mAb) antiteldir.
Xitoy, XARAJATLAR, Oshqozon, Gastroenterologiya, Hindiston, Isroil, Singapur, Oshqozon, muomala, AQSH
Ushbu dorilarni doimiy ravishda qabul qilish oshqozon saratoni xavfini ikki baravar oshirishi mumkin
"Intestine" da chop etilgan tadqiqot shuni ko'rsatdiki, proton pompasi inhibitörlerini uzoq vaqt davomida ishlatish oshqozon saratoni xavfini ikki baravar oshiradi. Proton nasos inhibitörleri, oshqozon kislotasi oqimini davolash uchun ishlatiladigan dorilar sinfidir. , Thi dan doimiy foydalanish ..
Xitoy, Hindiston, Isroil, Ramucirumab, Singapur, muomala, AQSH
Ramucirumab oshqozon saratonini davolashda
Statistik ma'lumotlarga ko'ra, Qo'shma Shtatlar, Evropa va Yaponiyada davolangan oshqozon saratoniga chalingan bemorlarga ramucirumabni oshqozon saratonini davolash uchun boshqa dorilar bilan birgalikda qo'llash tavsiya etiladi.
Xitoy, Kombinatsiyalangan terapiya, Hindiston, Jigar, PD-1 inhibitori, Roche, AQSH
Roche PD-1 inhibitori jigar saratoni kombinatsiyasi terapiyasi FDA tomonidan kashfiyot terapiyasi sifatida tan olingan
Kecha Shveytsariyaning Roche Group kompaniyasi TECENTRIQ® (atezolizumab) ni Avastin® (bevacizumab) bilan birgalikda AQSh oziq-ovqat va farmatsevtika idorasi (FDA) tomonidan dastlabki (birinchi qator) terapiya uchun tasdiqlanganligini e'lon qildi.
Kabozantinib, Xitoy, Hindiston, Jigar, AQSH
Kabozantinib jigarning rivojlangan saraton kasalligi uchun progressiyasiz hayotni uzaytiradi
5-iyul kuni New England Journal of Medicine jurnalida chop etilgan bir tadqiqotga ko'ra, rivojlangan gepatotsellulyar karsinomli bemorlarda Cabozantinibning umumiy va progressiv hayot kechirishi p .. ga nisbatan ancha yaxshi edi.